Patrick Kaltenbach, EVP & President Life Sciences at BECTON DICKINSON & CO (BDX), sold 4,575 shares at $263.23 ($1.2M) on 2019-12-12, disclosed to the SEC on 2019-12-16.
Open-market sale of $1.2M BDX by EVP & President Life Sciences. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $263.23 | 339 | $89K | 7.4% |
| 2 | $263.23 | 339 | $89K | 7.4% |
| 3 | $263.23 | 3,897 | $1.0M | 85.2% |
| Total | $263.23 avg | 4,575 | $1.2M | 100% |
| Filing → |
| MTD | BUY | 2021-02-19 | $59K | — | Filing → |
| BDX | SELL | 2020-07-13 | $331K | — | Filing → |
| BDX | SELL | 2020-06-05 | $510K | — | Filing → |